Abstract
Background
Vitamin D deficiency and systemic inflammation share common pathological mechanisms in muscle loss, cardio-pulmonary function decline, and abnormal metabolism, which are linked to chronic conditions, senescence, and early mortality. However, their combined effect on mortality in older adults has not been well established. This study longitudinal aimed to explore the independent and combined associations of serum 25-hydroxyvitamin D [25(OH)D] and high sensitivity C-reactive protein (hs-CRP) with mortality risk in Chinese community-based older people.
Methods
3072 older adults (86.07 ± 11.87 years, 54.52% female) from the Chinese Longitudinal Healthy Longevity Survey (2012–2018) were enrolled. Baseline 25(OH)D and hs-CRP levels were collected, and survival information was recorded in the 2014 and 2018 follow-up waves. Cox proportional hazard regressions were conducted to explore the associations between 25(OH)D, hs-CRP, and mortality. Demographic characteristics, health behaviors, and chronic disease biomarkers were adjusted.
Results
During 10,622.3 person-years of follow-up (median: 3.51 years), 1321 older adults died, including 448 deaths due to cardiovascular disease (CVD). Increased mortality risk was associated with lower 25(OH)D and higher hs-CRP quantiles, even after adjusting for each other and multiple covariates (all P-trend < 0.05). In combined analyses, the highest all-cause mortality (HR: 2.18, 95% CI: 1.73 ~ 2.56), CVD mortality (HR: 2.30, 95% CI: 1.64 ~ 3.21), and non-CVD mortality (HR: 2.19, 95% CI: 1.79 ~ 2.49) were obtained in participants with both 25(OH)D deficiency (< 50 nmol/L) and high hs-CRP (≥ 3.0 mg/L), respectively. We observed significant additive interactions of 25(OH)D and hs-CRP on all-cause mortality and non-CVD mortality (RERIS>0).
Conclusions
Low 25(OH)D and high hs-CRP, both independently and jointly, increase mortality risk in Chinese community-dwelling older adults. Thus, priority should be given to early detection and appropriate intervention in older individuals with combined vitamin D deficiency and systemic inflammation. Molecular mechanisms of related adverse health effect are worthy of further investigation.
Similar content being viewed by others
Background
Vitamin D is an important prominent micronutrient that is primarily involved in maintaining calcium homeostasis, which is mainly stored as 25(OH)D in the body [1]. Vitamin D deficiency has become a prevalent global health problem, particularly among individuals residing in develo** nations, including China [2]. A recent meta-analysis of 472 research reports demonstrated that the prevalence of vitamin D deficiency, characterized by serum 25(OH)D level under 50 nmol/L, was 57.7% in the Asian demographic [3]. Associations of vitamin D levels and supplementation with mortality are not exactly consistent in published observational and intervention literatures though vitamin D has been linked to several potential health benefits [4,5,6]. Numerous studies have linked vitamin D deficiency with various negative health consequences, including fractures [7], frailty [8], sarcopenia [9], dementia [10], and premature death [11, 39, 53], which might be a new approach to explain the complex association between vitamin D and multiple health outcomes in the future. Meanwhile, as for CVD mortality, serum 25(OH)D can regulate the renin-angiotensin system and the proliferation of vascular smooth muscle cells [54, 55], reducing the incidence of CVD diseases [56]. Besides, insufficient vitamin D was also found to be associated with depression, schizophrenia, and Alzheimer’s disease [12, 57]. The high prevalence of these diseases contributes to a significantly higher likelihood of future non-CVD mortality.
We also demonstrated that high hs-CRP was associated with increased all-cause, CVD, and non-CVD mortality. Similar findings were obtained from studies performed in the United States [19], Peru [38], and China [21]. A previous meta-analysis involving 22 studies showed significant positive relationships of hs-CRP with all-cause and CVD mortality [58]. Fundamental studies have also showed that hs-CRP could inhibit vascular endothelial growth factor-stimulated angiogenesis and indirectly promote vasoconstriction, thrombosis, and atherosclerosis [59, 60], increasing the risk of death from CVD [61]. Several cohort studies confirmed that hs-CRP was linked to the incidence and progression of cardiovascular and cerebrovascular events [62, 63]. High hs-CRP is also correlated with higher risks of various chronic disorders like diabetes [64], dementia [65], and cancer [66]. Furthermore, hs-CRP has been identified as a biomarker with poor prognosis for many diseases, such as cancer and myocardial infarction [67, 68]. These results suggest that high hs-CRP not only increases the risk of morbidity but also may lead to poor prognosis and thus increase the risk of death.
Although our findings on the separate association of 25(OH)D and hs-CRP with mortality were not novel, the innovative result was that vitamin D deficiency and high hs-CRP jointly increased risks of all-cause mortality by 118%, CVD mortality by 130%, and non-CVD mortality by 119%, which were higher than their individual effects. Significant additive interactions of 25(OH)D and hs-CRP on all-cause and non-CVD mortality were observed (RERIS>0), particularly in men. Some mechanisms may explain the combined association of vitamin D and hs-CRP with mortality. First, previous experimental studies have found that 25(OH)2D3, which is an active version of vitamin D, inhibits the synthesis of multiple inflammatory cytokines [69]. A population-based observational study also found that elevated circulatory 25(OH)D was significantly correlated with lower hs-CRP levels [70]. These results suggested that low serum 25(OH)D might contribute to high hs-CRP because of its anti-inflammatory properties. Therefore, vitamin D deficiency and high hs-CRP could aggravate each other, jointly increasing the risk of death. Second, vitamin D deficiency and high hs-CRP are included in common pathogenic factors of death which may ultimately increase the mortality risk. Previous studies have demonstrated that the coexistence of vitamin D deficiency and high hs-CRP was associated with a higher prevalence of sarcopenia [71, 72], CVD [27], schizophrenia [28], and metabolic syndrome [29]. Considering the potential confounding of clinical factors, we conducted multiple sensitivity analyses to test the stability of the main results. The combined associations of 25(OH)D and hs-CRP with mortality were materially unchanged after excluding participants with cerebrovascular disease, respiratory disease, or cancer at baseline. Interestingly, we found the effects of vitamin D deficiency and high hs-CRP on mortality risk were weaker in older adults who received inpatient or outpatient medical services in the last year (Supplementary Table 4). One possible reason was that vitamin D deficiency and inflammation might be treated with medical intervention when older people were cared for in medical facilities. Thus, we recommended focusing on the heterogeneity between clinical settings and healthy community samples in future studies.
Strengths and limitations
This study focused on the interactions between multiple biomarkers and provides valuable epidemiological evidence. In the current study, 16.3% of older adults exhibited both vitamin D deficiency and high hs-CRP. Considering the combined association of vitamin D and hs-CRP with mortality, intervention strategies for maintaining adequate vitamin D and preventing inflammation may be beneficial in reducing mortality risk in community settings. The current study has several limitations. Firstly, while hs-CRP is a commonly used marker for systemic inflammation [73, 74], the present study did not account for other inflammatory factors, such as acute infections, autoimmune diseases, or anti-inflammatory drug use, etc. However, after excluding the outliers of hs-CRP measurements (≥ 10 mg/L), the main results remained stable, which may have partially eliminated the influence of immune-related diseases (Supplementary Table 2). Secondly, like other observational analyses, it is not possible to eliminate the residual confounding factors even after multivariable adjustment. Specifically, data on sunlight exposure was not available at baseline. To mitigate this limitation, we attempted to control for factors such as outdoor activity frequency, the month of the blood sampling, and residential provinces, following previous studies [39, 40]. Additionally, we were unable to quantify the supplementation of vitamin D. However, in this study, only a very small percentage (5.50%) of older individuals frequently supplemented with vitamins, which might not significantly confound the associations. Furthermore, when they were excluded, the relationship between vitamin D levels and the risk of mortality remained stable (Supplementary Table 5). Thirdly, we only measured serum 25(OH)D and hs-CRP levels from a single time point. Given that both may vary due to changes in lifestyle or health status, it is necessary to explore their dynamic effect on health consequences in in the future. Finally, despite the national representation of CLHLS, caution should be exercised when generalizing the findings to older people of other ethnicities.
Conclusions
This study highlighted that the combination of low 25(OH)D and high hs-CRP levels could jointly elevate the risk of mortality in older adults. Thus, it is crucial to prioritize early detection and appropriate intervention for individuals who exhibit a combination of vitamin D deficiency and systemic inflammation.
Data availability
The raw data used in the current study can be found here: https://opendata.pku.edu.cn/dataverse/CHADS.
Abbreviations
- 25(OH)D:
-
25-dihydroxyvitamin D
- hs-CRP:
-
high sensitivity C-reactive protein
- CLHLS:
-
Chinese Longitudinal Healthy Longevity Survey
- CVD:
-
cardiovascular disease
- BMI:
-
body mass index
- ADL:
-
activities of daily living
- HR:
-
hazard ratios
- CI:
-
confidence interval
References
Krist AH, Davidson KW, Mangione CM, Cabana M, Caughey AB, Davis EM, Donahue KE, Doubeni CA, Epling JW Jr., Kubik M, et al. Screening for vitamin D Deficiency in adults: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(14):1436–42.
Palacios C, Gonzalez L. Is vitamin D deficiency a major global public health problem? J Steroid Biochem Mol Biol. 2014;144(Pt):138–45.
Jiang Z, Pu R, Li N, Chen C, Li J, Dai W, Wang Y, Hu J, Zhu D, Yu Q et al. High prevalence of vitamin D deficiency in Asia: a systematic review and meta-analysis. Crit Rev Food Sci Nutr 2021:1–10.
Keum N, Lee DH, Greenwood DC, Manson JE, Giovannucci E. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30(5):733–43.
Zhang Y, Fang F, Tang J, Jia L, Feng Y, Xu P, Faramand A. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:l4673.
Pilz S, Grübler M, Gaksch M, Schwetz V, Trummer C, Hartaigh B, Verheyen N, Tomaschitz A, März W. Vitamin D and mortality. Anticancer Res. 2016;36(3):1379–87.
Busse B, Bale HA, Zimmermann EA, Panganiban B, Barth HD, Carriero A, Vettorazzi E, Zustin J, Hahn M, Ager JW 3, et al. Vitamin D deficiency induces early signs of aging in human bone, increasing the risk of fracture. Sci Transl Med. 2013;5(193):193ra188.
Marcos-Pérez D, Sánchez-Flores M, Proietti S, Bonassi S, Costa S, Teixeira JP, Fernández-Tajes J, Pásaro E, Valdiglesias V, Laffon B. Low vitamin D levels and Frailty Status in older adults: a systematic review and Meta-analysis. Nutrients. 2020;12(8):2286.
Yang A, Lv Q, Chen F, Wang Y, Liu Y, Shi W, Liu Y, Wang D. The effect of vitamin D on Sarcopenia depends on the level of physical activity in older adults. J Cachexia Sarcopenia Muscle. 2020;11(3):678–89.
Jayedi A, Rashidy-Pour A, Shab-Bidar S. Vitamin D status and risk of dementia and Alzheimer’s disease: a meta-analysis of dose-response (†). Nutr Neurosci. 2019;22(11):750–9.
Sutherland JP, Zhou A, Hyppönen E. Vitamin D Deficiency increases Mortality Risk in the UK Biobank: a nonlinear mendelian randomization study. Ann Intern Med. 2022;175(11):1552–9.
Yue Z, Liang H, Gao X, Qin X, Li H, **ang N, Liu E. The association between falls and anxiety among elderly Chinese individuals: the mediating roles of functional ability and social participation. J Affect Disord. 2022;301:300–6.
Autier P, Boniol M, Pizot C, Mullie P. Vitamin D status and ill health: a systematic review. Lancet Diabetes Endocrinol. 2014;2(1):76–89.
Goldberg EL, Dixit VD. Drivers of age-related inflammation and strategies for healthspan extension. Immunol Rev. 2015;265(1):63–74.
Beavers DP, Kritchevsky SB, Gill TM, Ambrosius WT, Anton SD, Fielding RA, King AC, Rejeski WJ, Lovato L, McDermott MM, et al. Elevated IL-6 and CRP levels are Associated With Incident Self-reported major mobility disability: a pooled analysis of older adults with slow gait speed. J Gerontol A Biol Sci Med Sci. 2021;76(12):2293–9.
Soysal P, Stubbs B, Lucato P, Luchini C, Solmi M, Peluso R, Sergi G, Isik AT, Manzato E, Maggi S, et al. Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev. 2016;31:1–8.
Li Y, Zhong X, Cheng G, Zhao C, Zhang L, Hong Y, Wan Q, He R, Wang Z. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: a meta-analysis. Atherosclerosis. 2017;259:75–82.
Devaraj S, O’Keefe G, Jialal I. Defining the proinflammatory phenotype using high sensitive C-reactive protein levels as the biomarker. J Clin Endocrinol Metabolism. 2005;90(8):4549–54.
Zipperer MB, Churilla JR, Stapleton JN, Richardson MR. Joint effect of cognitive function and C-reactive protein on all-cause mortality risk: 1999–2002 NHANES. Ann Epidemiol. 2022;74:111–7.
Sung KC, Ryu S, Chang Y, Byrne CD, Kim SH. C-reactive protein and risk of cardiovascular and all-cause mortality in 268 803 East asians. Eur Heart J. 2014;35(27):1809–16.
Chen PL, Li ZH, Yang HL, Cao ZJ, Cheng X, Zhao F, Zhang XR, Lv YB, Li FR, Zhou YF, et al. Associations between high-sensitivity C-Reactive protein and all-cause Mortality among Oldest-Old in Chinese Longevity areas: A Community-based Cohort Study. Front Public Health. 2022;10:824783.
Hu FB. Metabolic profiling of diabetes: from black-box epidemiology to systems epidemiology. Clin Chem. 2011;57(9):1224–6.
Kruit A, Zanen P. The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases. Clin Biochem. 2016;49(7):534–7.
Haussler MR, Whitfield GK, Kaneko I, Haussler CA, Hsieh D, Hsieh J-C, Jurutka PW. Molecular mechanisms of vitamin D action. Calcif Tissue Int. 2013;92(2):77–98.
Ansar W, Ghosh S. C-reactive protein and the biology of disease. Immunol Res. 2013;56(1):131–42.
Luan Y-y. Yao Y-m: the clinical significance and potential role of C-reactive protein in chronic inflammatory and neurodegenerative diseases. Front Immunol. 2018;9:1302.
Li Q, Dai Z, Cao Y, Wang L. Association of C-reactive protein and vitamin D deficiency with cardiovascular disease: a nationwide cross-sectional study from National Health and Nutrition Examination Survey 2007 to 2008. Clin Cardiol. 2019;42(7):663–9.
Zhu DM, Liu Y, Zhang AG, Chu ZX, Wu Q, Li H, Ge JF, Dong Y, Zhu P. High levels of vitamin D in relation to reduced risk of schizophrenia with elevated C-reactive protein. Psychiatry Res. 2015;228(3):565–70.
Fassula AS, Gonzalez-Chica D, Giehl MC, Silva DAS, Cembranel F, Moreno YMF. Moderator role of vitamin D concentrations on the association between metabolic syndrome and C-reactive protein among adults. Arch Endocrinol Metab. 2021;64(6):695–703.
Zhu C, Walsh C, Zhou L, Zhang X. Latent classification analysis of leisure activities and their impact on ADL, IADL and cognitive ability of older adults based on CLHLS (2008–2018). Int J Environ Res Public Health. 2023;20(2):1546.
Zeng Y, Feng Q, Gu D, Vaupel JW. Demographics, phenotypic health characteristics and genetic analysis of centenarians in China. Mech Ageing Dev. 2017;165(Pt B):86–97.
Lv Y, Mao C, Yin Z, Li F, Wu X, Shi X. Healthy ageing and biomarkers Cohort Study (HABCS): a cohort profile. BMJ Open. 2019;9(10):e026513.
Matchar DB, Chei CL, Yin ZX, Koh V, Chakraborty B, Shi XM, Zeng Y. Vitamin D levels and the risk of Cognitive decline in Chinese Elderly people: the Chinese longitudinal healthy longevity survey. J Gerontol A Biol Sci Med Sci. 2016;71(10):1363–8.
Lv YB, Yin ZX, Chei CL, Qian HZ, Kraus VB, Zhang J, Brasher MS, Shi XM, Matchar DB, Zeng Y. Low-density lipoprotein cholesterol was inversely associated with 3-year all-cause mortality among Chinese oldest old: data from the Chinese longitudinal healthy longevity survey. Atherosclerosis. 2015;239(1):137–42.
Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CM. Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–30.
Zhai Y, Shi XM, Fitzgerald SM, Qian HZ, Kraus VB, Sereny M, Hu P, Yin ZX, Xu JW, Zeng Y. High sensitivity C-reactive protein associated with different health predictors in middle-aged and oldest old Chinese. Biomed Environ Sci. 2012;25(3):257–66.
Chen C, Liu Y, Cao Z, Yin Z, Zhao F, Lv Y, Liu Z, Mao C, Song S, Liu L, et al. Combined associations of hs-CRP and cognitive function with all-cause mortality among oldest-old adults in Chinese longevity areas: a prospective cohort study. Immun Ageing. 2019;16:30.
Bernabe-Ortiz A, Carrillo-Larco RM, Gilman RH, Smeeth L, Checkley W, Miranda JJ. High-sensitivity C-reactive protein and all-cause mortality in four diverse populations: the CRONICAS Cohort Study. Ann Epidemiol. 2022;67:13–8.
** X, **ong S, Ju SY, Zeng Y, Yan LL, Yao Y. Serum 25-Hydroxyvitamin D, Albumin, and Mortality among Chinese older adults: a Population-based Longitudinal Study. J Clin Endocrinol Metab. 2020;105(8):dgaa349.
Wan Z, Guo J, Pan A, Chen C, Liu L, Liu G. Association of serum 25-Hydroxyvitamin D concentrations with all-cause and cause-specific mortality among individuals with diabetes. Diabetes Care. 2021;44(2):350–7.
Lin SW, Chen W, Fan JH, Dawsey SM, Taylor PR, Qiao YL, Abnet CC. Prospective study of serum 25-hydroxyvitamin D concentration and mortality in a Chinese population. Am J Epidemiol. 2012;176(11):1043–50.
Lv X, Li W, Ma Y, Chen H, Zeng Y, Yu X, Hofman A, Wang H. Cognitive decline and mortality among community-dwelling Chinese older people. BMC Med. 2019;17(1):63.
Andersson T, Alfredsson L, Källberg H, Zdravkovic S, Ahlbom A. Calculating measures of biological interaction. Eur J Epidemiol. 2005;20(7):575–9.
Knol MJ, van der Tweel I, Grobbee DE, Numans ME, Geerlings MI. Estimating interaction on an additive scale between continuous determinants in a logistic regression model. Int J Epidemiol. 2007;36(5):1111–8.
Fan X, Wang J, Song M, Giovannucci EL, Ma H, ** G, Hu Z, Shen H, Hang D. Vitamin D status and risk of all-cause and cause-specific mortality in a large cohort: results from the UK Biobank. J Clin Endocrinol Metab 2020, 105(10).
Zeng J, Li T, Sun B, Miao X, Wang L, Ma LC, Li N, Gong Y, He Y, Li C, et al. Change of vitamin D status and all-cause mortality among Chinese older adults: a population-based cohort study. BMC Geriatr. 2022;22(1):245.
Bikle D, Christakos S. New aspects of vitamin D metabolism and action - addressing the skin as source and target. Nat Rev Endocrinol. 2020;16(4):234–52.
Bouillon R, Marcocci C, Carmeliet G, Bikle D, White JH, Dawson-Hughes B, Lips P, Munns CF, Lazaretti-Castro M, Giustina A, et al. Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40(4):1109–51.
Iuliano S, Poon S, Robbins J, Bui M, Wang X, De Groot L, Van Loan M, Zadeh AG, Nguyen T, Seeman E. Effect of dietary sources of calcium and protein on hip fractures and falls in older adults in residential care: cluster randomised controlled trial. BMJ. 2021;375:n2364.
Bikle D. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009;94(1):26–34.
Martens PJ, Gysemans C, Verstuyf A, Mathieu AC. Vitamin D’s Effect on Immune Function. Nutrients 2020, 12(5).
Aranow C. Vitamin D and the immune system. J Investig Med. 2011;59(6):881–6.
Kositsawat J, Kuo C-L, Barry LC, Melzer D, Bandinelli S, Ferrucci L, Wu R, Kuchel GA. Interaction between vitamin D and interleukin 6 on slow gait speed: 6-Year follow-up data of older adults from InCHIANTI. The Journals of Gerontology: Series A. 2019;75(6):1161–6.
Al Mheid I, Patel RS, Tangpricha V, Quyyumi AA. Vitamin D and cardiovascular disease: is the evidence solid? Eur Heart J. 2013;34(48):3691–8.
Schnatz PF, Nudy M, O’Sullivan DM, Jiang X, Cline JM, Kaplan JR, Clarkson TB, Appt SE. The quantification of vitamin D receptors in coronary arteries and their association with atherosclerosis. Maturitas. 2012;73(2):143–7.
Gunta SS, Thadhani RI, Mak RH. The effect of vitamin D status on risk factors for cardiovascular disease. Nat Rev Nephrol. 2013;9(6):337–47.
Anglin RE, Samaan Z, Walter SD, McDonald SD. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Br J Psychiatry. 2013;202:100–7.
Ni P, Yu M, Zhang R, Cheng C, He M, Wang H, Chen S, Duan G. Dose-response association between C-reactive protein and risk of all-cause and cause-specific mortality: a systematic review and meta-analysis of cohort studies. Ann Epidemiol. 2020;51:20–27e11.
Lakoski SG, Cushman M, Palmas W, Blumenthal R, D’Agostino RB Jr., Herrington DM. The relationship between blood pressure and C-reactive protein in the multi-ethnic study of atherosclerosis (MESA). J Am Coll Cardiol. 2005;46(10):1869–74.
Calabrò P, Golia E, Yeh ET. CRP and the risk of atherosclerotic events. Semin Immunopathol. 2009;31(1):79–94.
Kaura A, Hartley A, Panoulas V, Glampson B, Shah ASV, Davies J, Mulla A, Woods K, Omigie J, Shah AD, et al. Mortality risk prediction of high-sensitivity C-reactive protein in suspected acute coronary syndrome: a cohort study. PLoS Med. 2022;19(2):e1003911.
Liu Y, Zhang C, Jiang L, Xu L, Tian J, Zhao X, Feng X, Wang D, Zhang Y, Sun K, et al. Relationship between high-sensitivity C-Reactive protein and long-term outcomes in Elderly patients with 3-Vessel disease. Angiology. 2022;73(1):60–7.
Ridker PM. High-sensitivity C-reactive protein: potential adjunct for global risk assessment in the primary prevention of cardiovascular disease. Circulation. 2001;103(13):1813–8.
Wang X, Bao W, Liu J, Ouyang YY, Wang D, Rong S, **ao X, Shan ZL, Zhang Y, Yao P, et al. Inflammatory markers and risk of type 2 diabetes: a systematic review and meta-analysis. Diabetes Care. 2013;36(1):166–75.
Hegazy SH, Thomassen JQ, Rasmussen IJ, Nordestgaard BG, Tybjaerg-Hansen A, Frikke-Schmidt R. C-reactive protein levels and risk of dementia-observational and genetic studies of 111,242 individuals from the general population. Alzheimers Dement. 2022;18(11):2262–71.
Zhu M, Ma Z, Zhang X, Hang D, Yin R, Feng J, Xu L, Shen H. C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and mendelian randomization analysis. BMC Med. 2022;20(1):301.
Lee M, Lee K, Kim DW, Cho JS, Kim TS, Kwon J, Kim CJ, Park CS, Kim HY, Yoo KD, et al. Relationship of serial high-sensitivity C-Reactive protein changes to long-term clinical outcomes in stabilised patients after myocardial infarction. Can J Cardiol. 2022;38(1):92–101.
Sugimoto A, Toyokawa T, Miki Y, Yoshii M, Tamura T, Sakurai K, Kubo N, Tanaka H, Lee S, Muguruma K, et al. Preoperative C-reactive protein to albumin ratio predicts anastomotic leakage after esophagectomy for thoracic esophageal cancer: a single-center retrospective cohort study. BMC Surg. 2021;21(1):348.
Zhang Y, Leung DY, Richers BN, Liu Y, Remigio LK, Riches DW, Goleva E. Vitamin D inhibits monocyte/macrophage proinflammatory cytokine production by targeting MAPK phosphatase-1. J Immunol. 2012;188(5):2127–35.
** D, Zhu DM, Hu HL, Yao MN, Yin WJ, Tao RX, Zhu P. Vitamin D status affects the relationship between lipid profile and high-sensitivity C-reactive protein. Nutr Metab (Lond). 2020;17:57.
Petermann-Rocha F, Gray SR, Pell JP, Celis-Morales C, Ho FK. Biomarkers Profile of people with Sarcopenia: a cross-sectional analysis from UK Biobank. J Am Med Dir Assoc. 2020;21(12):2017. e2011-2017.e2019.
Remelli F, Vitali A, Zurlo A, Volpato S. Vitamin D Deficiency and Sarcopenia in older persons. Nutrients. 2019;11(12):2861.
Custodero C, Mankowski RT, Lee SA, Chen Z, Wu S, Manini TM, Hincapie Echeverri J, Sabbà C, Beavers DP, Cauley JA, et al. Evidence-based nutritional and pharmacological interventions targeting chronic low-grade inflammation in middle-age and older adults: a systematic review and meta-analysis. Ageing Res Rev. 2018;46:42–59.
Han S, Zhang F, Yu H, Wei J, Xue L, Duan Z, Niu Z. Systemic inflammation accelerates the adverse effects of air pollution on metabolic syndrome: findings from the China health and Retirement Longitudinal Study (CHARLS). Environ Res. 2022;215(Pt 1):114340.
Acknowledgements
The authors sincerely appreciate the contributions of staffs and participants at the Chinese Longitudinal Healthy Longevity Survey.
Funding
This work was supported by National High Level Hospital Clinical Research Funding (Number: BJ-2022-133) and National Key R&D Program of China (2021YFE0111800). CZ and HS are grant recipients for these programs. The funding agencies were not involved in study design; collection, management, analyses, and interpretation of data; writing of the report; and the decision to submit the report for publication.
Author information
Authors and Affiliations
Contributions
CZ and HS contributed to the concept and design of the study. JC, SJL and JS performed the data analysis. CZ drafted the manuscript. XML, YY and HS revised the manuscript. All authors have read and agreed to the published version of the manuscript.
Corresponding authors
Ethics declarations
Ethics approval and consent to participate
The study design was approved by the Ethics Committee of Bei**g Hospital. The CLHLS was approved by the Ethics Committee of Peking University (No. IRB00001052-13074). Written informed consent was obtained from all participants or their guardians (wherever applicable) prior to the study. All methods were performed in accordance with the relevant guidelines and regulations.
Consent for publication
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
12877_2024_4706_MOESM1_ESM.docx
Additional files: Supplementary Figure 1. Flowchart of participant recruitment and follow-up interviews. Supplementary Table 1. Sensitivity analysis of combined effects of 25(OH)D deficiency and high hs-CRP on mortality after excluding 26 participants with exorbitant measured values of serum 25(OH)D (≥100 nmol/L). Supplementary Table 2. Sensitivity analysis of combined effects of 25(OH)D deficiency and high hs-CRP on mortality after excluding 199 participants with exorbitant measured values of serum hs-CRP (≥10mg/L). Supplementary Table 3. Sensitivity analysis of combined effects of 25(OH)D deficiency and high hs-CRP on mortality after excluding participants with cerebrovascular disease, respiratory disease, or cancer at baseline. Supplementary Table 4. Subgroup analysis of combined effects of 25(OH)D deficiency and high hs-CRP on mortality stratified by medical care treatment. Supplementary Table 5. Associations of 25(OH)D with mortality risk after excluding 169 participants who frequently supplemented with vitamins. Supplementary Table 6. Combined associations of 25(OH)D deficiency and high hs-CRP with mortality risk after additionally adjusting for high-density lipoprotein and low-density lipoprotein.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Zhang, C., Cui, J., Li, S. et al. Combined effects of vitamin D deficiency and systemic inflammation on all-cause mortality and cause-specific mortality in older adults. BMC Geriatr 24, 122 (2024). https://doi.org/10.1186/s12877-024-04706-x
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12877-024-04706-x